Literature DB >> 24781034

Central nervous system manifestation of IgG4-related disease.

Keren Regev1, Tami Nussbaum1, Emanuela Cagnano2, Nir Giladi1, Arnon Karni1.   

Abstract

IMPORTANCE: IgG4-related disease (IgG4-RD) is characterized by an inflammatory reaction rich in IgG4-positive plasma cells. Head and brain involvement is rare in IgG4-RD, and brain parenchyma involvement has never been reported. OBSERVATION: A man in his mid-50s with multiorgan IgG4-RD developed progressive spastic hemiparesis and dementia. Magnetic resonance imaging of the brain revealed several cortical and subcortical lesions. Pathologic findings in the brain were consistent with IgG4-related central nervous system involvement. The patient was treated with high-dose corticosteroids followed by rituximab, and his cognitive and motor functions improved significantly. CONCLUSIONS AND RELEVANCE: IgG4-RD should be considered in patients with unusual neurologic manifestations suggestive of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24781034     DOI: 10.1001/jamaneurol.2014.40

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  11 in total

Review 1.  Immunology of IgG4-related disease.

Authors:  E Della-Torre; M Lanzillotta; C Doglioni
Journal:  Clin Exp Immunol       Date:  2015-06-08       Impact factor: 4.330

Review 2.  Inflammatory Disorders of the Skull Base: a Review.

Authors:  Pria Anand; Bart K Chwalisz
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

3.  Hypertrophic Pachymeningitis and Interstitial Lung Disease in IgG4-Related Disease.

Authors:  So Hyun Yim; Jae Seob Yoon; Chang Hun Lee; Jiyoung Kim
Journal:  J Clin Neurol       Date:  2022-07       Impact factor: 2.566

Review 4.  Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review.

Authors:  Aigli G Vakrakou; Maria-Eleptheria Evangelopoulos; Georgios Boutzios; Dimitrios Tzanetakos; John Tzartos; Georgios Velonakis; Panagiotis Toulas; Maria Anagnostouli; Elissavet Andreadou; Georgios Koutsis; Leonidas Stefanis; George E Fragoulis; Constantinos Kilidireas
Journal:  Rheumatol Int       Date:  2020-01-02       Impact factor: 2.631

5.  Clinical course of IgG4-related hypophysitis presenting with focal seizure and relapsing lymphocytic hypophysitis.

Authors:  Kanchana Ngaosuwan; Therdkiat Trongwongsa; Shanop Shuangshoti
Journal:  BMC Endocr Disord       Date:  2015-10-29       Impact factor: 2.763

Review 6.  Neurological Manifestations of IgG4-Related Disease.

Authors:  Bernardo Baptista; Alina Casian; Harsha Gunawardena; David D'Cruz; Claire M Rice
Journal:  Curr Treat Options Neurol       Date:  2017-04       Impact factor: 3.598

7.  Early treatment for IgG4-related disease may prevent cognitive impairment caused by cerebral vasculitis: A case report and review of the literature.

Authors:  Toshihiko Usami; Shoji Kawashima; Yoshino Ueki; Takanari Toyoda; Kenji Okita; Noriyuki Matsukawa
Journal:  eNeurologicalSci       Date:  2018-01-04

8.  A Series of Biopsy-proven Patients with Immunoglobulin G4-related Neurological Disease.

Authors:  Yareeda Sireesha; Megha S Uppin; Shridhar Ganti; Rajesh Alugolu; Vijaya Saradhi Mudumba; Suchanda Bhattacharjee; Mathukumalli L Neeharika; Jogendra Bastia; Meena Angamuthu Kanikannan
Journal:  Ann Indian Acad Neurol       Date:  2019 Jan-Mar       Impact factor: 1.383

9.  Cerebellar infarction as the initial presentation of IgG4-related disease.

Authors:  Branden Ireifej; Umaima Dhamrah; David Song; Joyce Bitar; Vikash Jaiswal; Gaurav Nepal; Nibesh Pathak; Majd Freijat
Journal:  Clin Case Rep       Date:  2022-03-17

10.  IgG4-related disease presenting with an epidural inflammatory pseudotumor: a case report.

Authors:  Nuno Ribeiro Ferreira; Rita Vaz; Sara Carmona; Sofia Mateus; Patrícia Pereira; Liliana Fernandes; Hugo Moreira; Martinha Chorão; Luís Saldanha; António Carvalho; Luís Campos
Journal:  J Med Case Rep       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.